A twice monthly nephrology journal club that meets on Twitter. Hashtag #NephJC
twittersphere
Joined April 2014
- Tweets52.2K
- Following1.2K
- Followers39.3K
- Likes31K
Pinned Tweet
#NephJC runs on community magic ✨
We choose to stay free and independent and give back to our community for 12yrs
🩵 If our blogs, podcasts, or visuals have helped you, your donation keeps us going - and might get you into the coolest #KidneyWk party
nephjc.com/news/2026/9/8/nep…
Nephrology Journal Club retweeted
#Kidneywk Run(s) at Denver
📍Friday October 23rd, 6:30 AM. Meet at the giant blue bear in front of the convention center
📍Saturday October 24th, 6 AM, Meet at the Hyatt Regency
@NephJC @runningkidneys @ASNKidney
nephjc.com/news/nephrun2026
Join the coolest kidney party of #KidneyWk! 🩵
Just 6 days to go! Grab your ticket here:
nephjc.com/news/2026/9/13/th…
🙏Thank you to everyone who has donated already. Your support keeps #NephJC moving forward
Nephrology Journal Club retweeted
#NephJC en IG
#nefroneando avanzamos
Did you know that #NephjC is on Instagram?
We turn most of the featured studies into a visual summary in just 6-7 images. Check out the latest one ✨
By @AncaSt13 & @CristinaDeReins
nephjc.com/news/2026/ig/tran…
Did you know that #NephjC is on Instagram?
We turn most of the featured studies into a visual summary in just 6-7 images. Check out the latest one ✨
By @AncaSt13 & @CristinaDeReins
nephjc.com/news/2026/ig/tran…
9/10
I want more info:
link to the NephJC blog by Urvashi, SM Assad and
VAs by Daniel
nephjc.com/news/transplantem…
10/10
Final thoughts:
Transplant benefits are certainly not universal and require careful conversations about individualized benefits.
Up next- ASN #KidneyWeek26 in Denver, CO. Hope to see you there! Check out NephJC.com, become a donor and for party details.
6/10
Question 1
#NephJC #NephTwitter
So, should we transplant all ESRD cases?
It depends. SCD kidneys improved mortality in all studied groups. However, SCD kidneys may not be readily available for all waitlisted patients. Worthy of discussion with older, sicker patients.
8/10
#NephJC Consensus:
In most cases, DDKT can improve survival compared to continued dialysis.
Not all donor kidneys are created equal (SCD, ECD, DCD, DBD).
Discussion of recipient and donor quality should be undertaken during transplant evaluation, as well of goals of care.
7/10
Question 2
#NephJC #NephTwitter
Should older/sicker patients risk transplant?
These are the individualized conversations that are needed. Although older pts receiving poorer kidneys (ECD) didn’t show mortality benefit, QoL is still an important consideration.
5/10
A picture paints 1000 words
As the donor & the recipient “quality” ⬇️, so do benefits. Although higher quality kidneys (SCD) did better in worse recipients (those >75, DM+, CVD+), should they have access to SCD kidneys if overall survival is ⬇️ than younger candidates?
3/10
1 post methods
-SCD, ECD, donor after brain death (DBD), donor after CV death (DCD)
-4 transplant groups: SCD/DBD, SCD/DCD, ECD/DBD, ECD/DCD were compared in 4 patient groups: All, DM+, CVD+, neither DM/CVD
The 16 trials generated 1,491,537 person-trials
2/10
What was the study?
🎯Target trial emulation: using collected data to mimic a randomized trial
🇪🇺 ERA registry: 2000-2019
✅Included: >20 years of age, waitlisted for receiving a kidney transplant
🧮60 sequential trial emulations
1/10
#NephJC #TenPostNephJC.
#NephTwitter
Patient outcomes are better with transplant vs dialysis.
Is this always true?
What about high-risk donors (expanded criteria donor-ECD) or recipients (elderly with DM or CVD)?
Read the article 👇
link to article on pubmed.ncbi.nlm.nih.gov/4275…
Check out the VA by @danyrcal
Do older, sicker patients benefit from kidney transplantation?
This is a nuanced "it depends" answer that is worthy of discussion. #NephTwitter
nephjc.com/news/targetva
🚨This week we are looking at a target trial emulation on transplantation.
Do older pts benefit from kidney transplant?
What if donation is after: CV death or brain death?
What if donor is a standard (SCD) or extended (ECD) criteria donor? #NephTwitter
nephjc.com/news/transplantem…
12 years of #NephJC. Countless papers discussed, ideas challenged, and friendships made.
🩵No paywalls. No pharma funding, just a community that believes in free, independent nephrology education.
🌟We need your help to keep it going. Please donate
nephjc.com/news/2026/9/8/nep…
Can tolvaptan keep up with 3% saline?
This within-subject study in healthy volunteers delivered a surprising answer - and a few eyebrow-raising physiology twist. Dive in #NephJC
✍️ by @DrSaiVani1
nephjc.com/news/tolvaptanhyp…
